Consuelo H. Wilkins


Senior Vice President and Senior Associate Dean for Health Equity and Inclusive Excellence, Professor of Medicine, Vanderbilt University Medical Center

Consuelo H. Wilkins, MD, MSCI, Professor of Medicine, is Senior Vice President and Senior Associate Dean for Health Equity and Inclusive Excellence at Vanderbilt University Medical Center. Dr. Wilkins is an elected member of the National Academy of Medicine and a nationally recognized thought leader in health equity and in addressing the elimination of systemic inequities that impact the health and well-being of racial/ethnic minorities. As a community engagement research scientist, Dr. Wilkinshas pioneered new approaches to engaging vulnerable, socioeconomically disadvantaged, and minority populations. She is Principal Investigator of three NIH-funded centers, the Vanderbilt-Miami-Meharry Center of Excellence in Precision Medicine and Population Health; the Center for Improving Clinical Trial Education Recruitment and Enrollment at CTSA Hubs; and the Vanderbilt Institute for Clinical and Translational Research.Dr. Wilkins earned a Bachelor of Science in microbiology and Doctor of Medicine from Howard University. She completed a residency in Internal Medicine at Duke University Medical Center and a Geriatric Medicine fellowship at Washington University School of Medicine/Barnes-Jewish Hospital. Following her medical training, she earned a Master of Science in Clinical Investigation from Washington University School of Medicine.

Read more

This Speaker's Sessions

Town Hall
Thursday Oct. 14
1:30-2:15 pm
Watch Replay
Now Live!

Disrupting Brain Health Through Technology: The Hope, the Challenge, the Future

Technology and data hold great promise for ending Alzheimer’s—from tailored prevention to detection, diagnosis, and precision treatments. Of course, these technologies will be meaningless to historically underserved or marginalized groups if they are developed without diverse populations in mind.  This session will explore how technology and data are deepening our understanding of Alzheimer’s disease and what needs to be done to ensure it is inclusive and accessible to all.   

View SessionWatch Replay